Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(2):151; doi:10.1093/jnci/dji027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Taylor, P. T.
Right arrow Articles by Haverstick, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, P. T.
Right arrow Articles by Haverstick, D.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

Peyton T. Taylor, Doris Haverstick

Affiliations of authors: Division of Gynecologic Oncology, Oregovomab (OvaRex) Phase 3 Collaborative Trial (IMPACT II) (PTT); Division of Clinical Pathology, University of Virginia Health System, Charlottesville, VA (DMH)

Correspondence to: Peyton T. Taylor, MD, Division of Gynecologic Oncology, P. O. Box 800712, Charlottesville, VA 22908 (e-mail:ptt9y@virginia.edu)

The first 10% of the full text of this article appears below.

Rustin et al. (1) have summarized a simplification of the guidelines for the definition of response in ovarian cancer clinical trials proposed by the Gynecologic Cancer Intergroup. The guidelines state that "Patients are not evaluable by CA125 if they have received mouse antibodies...." We believe this advisement deserves careful scrutiny and further . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)
Gordon J. S. Rustin
J Natl Cancer Inst 2005 97: 152. [Extract] [Full Text] [PDF]